Company Description

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States.

It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.

The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.

GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

GlucoTrack, Inc.

Country	United States
Founded	2001
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	6
CEO	Paul Goode

Contact Details

Address: 301 Route 17 North, Suite 800 Rutherford, New Jersey 07070 United States
Phone	201 842 7715
Website	glucotrack.com

Stock Details

Ticker Symbol	GCTK
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001506983
CUSIP Number	45824Q507
ISIN Number	US45824Q5071
Employer ID	98-0668934
SIC Code	3841

Key Executives

Name	Position
Paul V. Goode Ph.D.	Chief Executive Officer, President and Director
Drinda Benjamin	Vice President of Marketing
Avner Gal MBA, MSc.EE	Co-Founder, Chairman Emeritus, Consultant and Member of Scientific and Clinical Advisory Board
David Malka BA	Co-Founder
Peter C. Wulff	Chief Financial Officer

Latest SEC Filings

Date	Type	Title
Mar 19, 2025	8-K	Current Report
Mar 13, 2025	8-K	Current Report
Feb 26, 2025	8-K	Current Report
Feb 14, 2025	8-K	Current Report
Feb 5, 2025	424B5	Filing
Feb 5, 2025	8-K	Current Report
Feb 4, 2025	8-K	Current Report
Jan 30, 2025	8-K	Current Report
Jan 29, 2025	8-K	Current Report
Jan 21, 2025	8-K	Current Report

View All SEC Filings